April 14, 2021
Business News

NAMSA Acquires American Preclinical Services (APS), Becoming the Preeminent CRO Leader in Interventional and Surgical Preclinical Research Solutions


MINNEAPOLIS–()–NAMSA®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its acquisition of Minneapolis-based American Preclinical Services (APS), a full service preclinical CRO. This purchase follows NAMSA’s acquisition of New York-based Syntactx, a leading clinical research services CRO, in January 2021.

With the addition of APS’s portfolio of services, NAMSA will further enhance its already robust preclinical solutions by providing Sponsors with a broader range of laboratory models and analysis tools, including innovative surgical instrumentation and several state-of-the-art catheterization labs, imaging…



Click here to view the original article.

Related Posts

You might also like ...

Sopheon Bridges Gaps Between Digital and Physical Product Development with Launch of Accolade for Smart Products
Riassunto: Alkira collabora con Microsoft per trasformare il passaggio al cloud networking verso Azure
Personalized Loyalty Solutions Provider Exchange Solutions Raises Growth Funding